GeoVax Labs, Inc. (GOVX)

↓ Download CSV

CIK 0000832489 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, GeoVax Labs, Inc. reported revenue of $2.49M, down 37.1% from the prior year. The company ran a net loss, with a net margin of -862.3%. It held $6.34M in total assets against $2.52M in total liabilities.

Key ratios (FY2025)

-869.3%
Operating margin
-862.3%
Net margin
-561.2%
Return on equity
-37.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$2.49M$3.95M$0$81.5K$385.5K$1.82M$1.18M$963.2K$1.08M$828.9K
Operating Income-$21.64M-$25.14M-$26.74M-$14.03M-$18.75M-$2.82M-$2.37M-$2.56M-$2.17M-$3.27M
Net Income-$21.46M-$24.99M-$25.97M-$14.02M-$18.57M-$2.96M-$2.37M-$2.56M-$2.17M-$3.27M
EPS (Diluted)$-22.40$-120.46$-14.29$-12.39$-3.04
Total Assets$6.34M$8.16M$9.28M$31.35M$11.80M$10.39M$468.9K$642.1K$490.2K$610.2K
Total Liabilities$2.52M$3.11M$4.75M$7.44M$825.0K$2.04M$1.66M$811.3K
Shareholders' Equity$3.83M$5.05M$5.76M$26.60M$4.36M$9.57M-$1.57M-$1.02M-$321.1K$240.4K
Cash & Equivalents$3.09M$5.51M$6.45M$27.61M$11.42M$9.88M$283.3K$259.7K$312.7K$454.0K
Operating Cash Flow-$21.47M-$24.68M-$25.17M-$19.03M-$11.20M-$2.75M-$1.40M-$1.54M-$1.69M-$1.95M
Capital Expenditures$27.6K$20.7K$48.9K$134.3K$47.7K$156.8K$7.6K$4.3K
Shares Outstanding1.73M421.5K1.98M1.76M6.38M3.83M15.0K219106.74M55.24M